B7-33 research peptide, ≥98% purity by HPLC, CAS N/A (novel synthetic analogue), lyophilized powder for in-vitro laboratory research, Pure Peptides
HPLC Verified

Buy B7-33 Research Peptide

Supplied as a lyophilised powder and independently verified to ≥98% purity by HPLC and MS-UPLC analysis.

~2,850 g/mol≥98% (HPLC)N/A (novel synthetic analogue)

Ships Next Day

Orders confirmed before 12pm EST ship the same business day; orders after 12pm EST ship the next business day. Monday to Friday.

HPLC Verified

≥98% purity

Lyophilised

Powder format

Express Shipping

Cold-chain included

COA on Request

Every batch

What is B7-33?

B7-33 is a single-chain synthetic peptide based on the B-chain of human relaxin-2, designed to keep relaxin's anti-scarring and blood-vessel signaling while being easier to make. It is studied in animal research for its effects on tissue scarring in the heart, lungs, kidneys and liver.

  • Based on human relaxin-2, studied for relaxin-receptor signaling similar to the full hormone
  • Studied in animal research for its effects on tissue scarring and collagen buildup in organs
  • Investigated in three rodent models of organ scarring, with activity comparable to the parent hormone
  • Works on pathways involved in remodeling the tissue scaffold and turning over collagen

For research use only. Not approved for human therapeutic use.

B7-33 is a synthetic single-chain peptide analogue of human relaxin-2 with a molecular weight of 2987.75 g/mol. Its structure corresponds to residues 7 through 33 of the B-chain of relaxin-2, a 27-amino acid linear fragment that retains the receptor-binding determinants for the relaxin family peptide receptor 1 (RXFP1) while eliminating the two-chain disulfide-linked architecture of the native heterodimeric relaxin-2 hormone. B7-33 was designed as a simplified, single-chain alternative that maintains RXFP1 binding and activation. Produced via solid-phase peptide synthesis, B7-33 is associated with RXFP1-mediated signalling and extracellular matrix remodelling pathways.

B7-33 is a structurally simplified relaxin-2 mimetic that overcomes the challenges associated with the native two-chain disulfide hormone. In vitro studies have characterised B7-33 as a functionally selective agonist of RXFP1: it binds the receptor with lower affinity than native H2 relaxin and is only a weak activator of the cAMP pathway, yet it drives ERK1/2 phosphorylation with potency comparable to H2 relaxin in cells that natively express RXFP1, and increases expression of the collagen-degrading enzyme matrix metalloproteinase-2 (MMP-2) in human cardiac fibroblasts and rat renal myofibroblasts [1]. In vivo rodent studies have shown that B7-33 prevented or reversed organ fibrosis and dysfunction with potency similar to H2 relaxin across three preclinical rodent models, and that an acute bolus of B7-33 reproduced the rapid vasoprotective/vascular-function effects of serelaxin in rat mesenteric artery, small renal artery and abdominal aorta [1][2], making B7-33 a reference compound in preclinical cardiovascular and fibrosis research examining single-chain, functionally selective RXFP1 agonism and pERK1/2–MMP-2-directed extracellular matrix remodelling in rodent models.

B7-33 is produced to research-grade standards and independently verified by third-party HPLC and MS-UPLC analysis before dispatch. Vials are vacuum sealed and stored in a temperature controlled, monitored cold storage system. Certificates of Analysis are available on request.

Sold strictly for in vitro research purposes only. Not for human consumption. Intended for use by qualified researchers in laboratory settings only.

Scientific Review

Dr. Martina Rossi, PhD

Dr. Martina Rossi, PhD

Scientific Contributor and Reviewer

Reviewed for scientific accuracy, 14 June 2026

View credentials →

What Researchers Say

Sign in to leave a review

No reviews yet. Be the first to share your research experience.

Frequently Asked Questions

Related Compounds

HPLC Verified
TB-500 research peptide, ≥99% purity by HPLC, CAS 885340-08-9, lyophilized powder for in-vitro laboratory research, Pure Peptides
Out of Stock

TB-500

Mol. Wt.

4963.4 g/mol

Purity

≥99%

CAS No.

885340-08-9

from $78.00
HPLC Verified
BPC-157 research peptide, ≥98% purity by HPLC, CAS 137525-51-0, lyophilized powder for in-vitro laboratory research, Pure Peptides

BPC-157

Mol. Wt.

1,419.55 g/mol

Purity

≥98%

CAS No.

137525-51-0

from $42.00
HPLC Verified
KPV research peptide, ≥98% purity by HPLC, CAS 67727-97-3, lyophilized powder for in-vitro laboratory research, Pure Peptides
Out of Stock

KPV

Mol. Wt.

328.41 g/mol

Purity

≥98%

CAS No.

67727-97-3

from $36.50
HPLC Verified
LL-37 research peptide, ≥98% purity by HPLC, CAS 154947-66-7, lyophilized powder for in-vitro laboratory research, Pure Peptides
Out of Stock

LL-37

Mol. Wt.

4,493.34 g/mol

Purity

≥98%

CAS No.

154947-66-7

from $80.50
HPLC Verified
GHK-Cu (Copper Peptide) research peptide, ≥98% purity by HPLC, CAS 89030-95-5, lyophilized powder for in-vitro laboratory research, Pure Peptides
Out of Stock

GHK-Cu (Copper Peptide)

Mol. Wt.

403.91 g/mol

Purity

≥98%

CAS No.

89030-95-5

from $41.50
HPLC Verified
ARA-290 research peptide, ≥98% purity by HPLC, CAS 1195765-45-7, lyophilized powder for in-vitro laboratory research, Pure Peptides
Out of Stock

ARA-290

Mol. Wt.

~1,163 g/mol

Purity

≥98%

CAS No.

1195765-45-7

from $57.00

Select Size

Quantity

Quantity

vial

1

Need larger quantities? Contact us for bulk pricing

$31.00
Next batch coming soon

Get notified when this batch is released

Enter your email and we'll let you know as soon as this product is available again.

Independent HPLC purity verification on every batch
Dispatched next business day with cold-chain delivery
Temperature-controlled packaging from lab to door
Batch-specific Certificate of Analysis available on request

Quality Guaranteed

Every batch is HPLC-tested to ≥98% purity. Certificate of Analysis and MSDS available on request.

Your Cart

Your cart is empty

Add some research compounds to get started.

Browse Products